Etofibrate
99%
- Product Code: 74007
CAS:
31637-97-5
| Molecular Weight: | 363.79 g./mol | Molecular Formula: | C₁₈H₁₈ClNO₅ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00865727 | |
| Melting Point: | 48-52ºC | Boiling Point: | 214°C/0.3mmHg(lit.) |
| Density: | Storage Condition: | 2-8ºC |
Product Description:
Etofibrate is primarily used in the treatment of hyperlipidemia, a condition characterized by elevated levels of lipids in the blood. It works by reducing the levels of cholesterol and triglycerides, thereby helping to prevent cardiovascular diseases such as atherosclerosis, heart attacks, and strokes. The compound is often prescribed to patients who have not achieved desired lipid levels through diet and lifestyle changes alone. By improving lipid profiles, Etofibrate contributes to overall cardiovascular health and reduces the risk of long-term complications associated with high lipid levels. It is typically administered orally and is often part of a comprehensive treatment plan that includes dietary modifications and regular physical activity.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White Powder or Crystals |
| PURITY | 98.5 |
| MELTING POINT | 45-55 |
| NOTE: | This product is low melting point solid,may change state in different environments (solid, liquid or semi-solid) |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | €51.71 |
+
-
|
| 0.250 | 10-20 days | €170.16 |
+
-
|
Etofibrate
Etofibrate is primarily used in the treatment of hyperlipidemia, a condition characterized by elevated levels of lipids in the blood. It works by reducing the levels of cholesterol and triglycerides, thereby helping to prevent cardiovascular diseases such as atherosclerosis, heart attacks, and strokes. The compound is often prescribed to patients who have not achieved desired lipid levels through diet and lifestyle changes alone. By improving lipid profiles, Etofibrate contributes to overall cardiovascular health and reduces the risk of long-term complications associated with high lipid levels. It is typically administered orally and is often part of a comprehensive treatment plan that includes dietary modifications and regular physical activity.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :